Bryan Weingarten has played an important role in strengthening the Genetics and Personalized Cancer Prevention Program at Weill Cornell Medicine, helping advance a model of care that combines medical innovation with deeply personalized support for patients and families. His involvement reflects a belief that knowledge, access to expert care, and early intervention can meaningfully change the trajectory of people facing hereditary cancer risk.
“For me, supporting programs like this is about giving people clarity and confidence during moments that can otherwise feel overwhelming,” Bryan says. “When individuals understand their risk and have the right team around them, they’re able to make informed decisions about their health and their future.”
Since its founding, the program has served more than 500 patients, a milestone that reflects both the growing need for specialized genetic care and the collaborative support that allows the program to expand its reach. Bryan’s involvement has helped reinforce the program’s multidisciplinary approach, ensuring patients receive guidance that spans prevention, education, and long-term care tailored to each individual’s genetic profile.
“I’ve always believed that medicine should be proactive whenever possible,” Bryan adds. “Programs like this help people move from uncertainty to action, and that kind of empowerment is incredibly powerful.”
One of the most significant outcomes of Bryan’s support is the program’s ability to integrate dedicated psychosocial care into its prevention model. His gift made possible the addition of Emily Epstein, LMSW, a full-time clinical social worker who works closely with patients and families navigating hereditary cancer risk. Through counseling and family outreach initiatives, Emily helps ensure the program’s impact extends beyond the individual patient to relatives who may also benefit from genetic education and testing.
“Cancer risk doesn’t exist in isolation,” Bryan explains. “It affects entire families. Supporting a program that recognizes the emotional and family dynamics involved is incredibly important.”
Beyond philanthropy, Bryan remains actively engaged with the program and its broader mission. He frequently participates in educational events and conversations hosted by Weill Cornell Medicine, including recent discussions focused on advances in cancer prevention and genetics. These gatherings foster collaboration between physicians, researchers, and supporters who share a commitment to improving outcomes through early detection and education.
As Dr. Melissa Frey, MD, Director of the Genetics and Personalized Cancer Prevention Program, has noted, the program’s continued growth reflects the vision and generosity of supporters like Bryan. Through his partnership, the program is building a stronger framework for cancer prevention—one that prioritizes scientific progress while never losing sight of the individuals and families it serves.
“For me, this work is about impact,” Bryan says. “If we can help even one family better understand their risk and take steps toward prevention, then we’re moving in the right direction.”
Related Posts
